118th Congress Health
S. 2400: Securing Gene Synthesis Act
Introduced
- Introduced (completed)
- Passed Senate (not reached)
- Passed House (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Who scored on this bill
No member has earned points from it yet.
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Edward Markey
- S. 236: To amend the Act of August 9, 1955 (commonly known as the "Long-Term Leasing Act"), to authorize leases of up to 99 years for land in the Mashpee Wampanoag Tribe Reservation and land held in trust for the Wampanoag Tribe of Gay Head (Aquinnah), and for other purposes
- S. 2232: Expanding the Surety Bond Program Act of 2025
- S. 843: Sea Turtle Rescue Assistance and Rehabilitation Act of 2025
- S. 836: Children and Teens’ Online Privacy Protection Act
- S. 315: AM Radio for Every Vehicle Act of 2025
- S. 608: Deerfield River Wild and Scenic River Study Act of 2023
History
- Introduced in the Senate by Edward Markey.
Show the full action history (2 actions)
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.